BURU.AMEXNuburu, INC

S-1: NUBURU Files S-1 for Resale of 30M Shares Amidst Financial Strain

Sentiment:

Registration Statement


NUBURU, Inc. has filed an S-1 registration statement for the resale of up to 30 million shares of common stock by a selling stockholder, as the company navigates significant financial losses, a going concern warning, and a strategic pivot.

Delay expectedThe company was unable to achieve quorum for a stockholder meeting to approve securities issuable upon conversion of August 2024 Convertible Notes, forcing a delay in obtaining approval.The registration statement for the resale of shares issuable on conversion of the August 2024 Convertible Notes has not yet been declared effective by the SEC, causing a delay in liquidity for investors.The full TCEI acquisition is subject to continued due diligence, an acceptable third-party valuation, regulatory approvals (including Italian government's Golden Power review), and stockholder consent, which may cause delays.Entering into a new lease and appropriately equipping a replacement facility is costly and time-consuming and may cause delays in the company's progress with its new business strategy.
Capital raiseThe Standby Equity Purchase Agreement (SEPA) with YA II PN, LTD. allows the company to sell up to $100 million of common stock over 36 months, providing a potential source of capital.The company issued multiple convertible notes to Indigo Capital LP in March, April, July, and August 2025, for capital infusions and extinguishment of existing debt.A Business Loan and Security Agreement with Agile Capital Funding, LLC in May 2025 provided a capital infusion of $500,000, later refinanced to a $1,000,000 note with an additional $248,000 infusion.Securities Purchase Agreements with 1800 Diagonal Lending LLC and Boot Capital LLC in May and July 2025 provided capital infusions through convertible promissory notes.Convertible note transactions with Brick Lane Capital Management Limited, Bomore Opportunity Group Ltd, and Torcross Capital LLC in June 2025 provided capital infusions and facilitated preferred stock transfers.A convertible facility with Supply@ME Capital Plc (SYME) for up to $5.15 million is expected to be funded by SFE EI, with the company potentially holding a controlling interest in SYME upon conversion.The Yorkville Promissory Note, closed in July 2025, provided a capital infusion of $1,100,000 through a $1,250,000 debenture, with proceeds from the SEPA required for its repayment.S.F.E. Equity Investments SARL (SFE EI) agreed to commit capital to finance operations for the next twelve months as part of the Transformation Plan.
Worse than expectedThe net loss for the six months ended June 30, 2025, significantly increased to $28,836,400 from $18,343,981 in the prior year, indicating deteriorating financial performance.Revenue for the six months ended June 30, 2025, was nil, a sharp decline from $142,827 in the same period of 2024, reflecting a halt in commercial operations.The company's cash and cash equivalents are critically low at $111,090 as of June 30, 2025, highlighting severe liquidity constraints.The company received a NYSE American Notice of Noncompliance and is trading with a '.BC' designation, indicating a risk of delisting.The company's patent portfolio was foreclosed upon, and all inventory, property, and equipment at its leased facility were written down to zero due to a lease default and judgment, indicating significant asset loss and operational disruption.The company explicitly states 'substantial doubt about the Company's ability to continue as a going concern'.

Summary

  • NUBURU, Inc. (BURU) filed an S-1 registration statement for the resale of up to 30 million shares of its common stock by YA II PN, LTD. (the Selling Stockholder).
  • The company will not receive any proceeds from the resale of these shares by the Selling Stockholder, but may receive up to $97 million in aggregate gross proceeds from direct sales to the Selling Stockholder under a Standby Equity Purchase Agreement (SEPA).
  • As of August 20, 2025, NUBURU had sold 12,467,204 shares of Common Stock to the Selling Stockholder under the SEPA.
  • NUBURU reported a net loss of $28,836,400 for the six months ended June 30, 2025, a significant increase from $18,343,981 for the same period in 2024.
  • Revenue for the six months ended June 30, 2025, was nil, down from $142,827 in the prior year period, primarily due to cost reduction measures including employee furloughs.
  • The company's accumulated deficit reached $150,244,955 as of June 30, 2025, and cash and cash equivalents were critically low at $111,090.
  • NUBURU received a Notice of Noncompliance from NYSE American on April 29, 2025, for failing to maintain minimum stockholders' equity and reporting losses in two of its three most recent fiscal years; a compliance plan has been accepted with a deadline of October 29, 2026.
  • The company's patent portfolio was transferred to senior secured lenders in Q1 2025 through a foreclosure sale, extinguishing $8,961,872 of junior and senior secured notes.
  • NUBURU is pivoting its business strategy to diversify its asset base through acquisitions and focus its laser business on licensing and joint development in specific verticals, particularly the defense industry.
  • The company is pursuing acquisitions, including a controlling interest in defense-tech company Tekne S.p.A. and a SaaS startup focused on operational resilience, with initial stages completed and further stages requiring regulatory and stockholder approval.
  • NUBURU entered into a convertible facility with Supply@ME Capital Plc (SYME) for up to $5.15 million, aiming for a controlling interest in SYME, a fintech platform for inventory monetization.
  • The company's Series A Preferred Stock became mandatorily redeemable on January 31, 2025, for $10.00 per share, reclassifying it as a current liability, but NUBURU does not have legally available funds for redemption.
  • A 1-for-40 reverse stock split was effected on July 23, 2024, and authorized common stock shares were increased from 250 million to 900 million on July 22, 2025.

Sentiment

Score: 2

Explanation: The company is in a precarious financial position with recurring and increasing net losses, nil revenue, critically low cash, and a going concern warning. The loss of its patent portfolio, asset impairments due to lease default, and NYSE non-compliance are severe negative indicators. While strategic pivots and capital raises are in progress, their success is uncertain and the current state is highly distressed.

Positives

  • The company's stockholders approved issuances of Common Stock in excess of the 19.9% Exchange Cap for the SEPA and Indigo Capital notes, facilitating future financing.
  • The company successfully extinguished $8,961,872 of junior and senior secured notes through a foreclosure sale of its patent portfolio, eliminating long-term secured indebtedness.
  • NUBURU's compliance plan with NYSE American regarding its listing deficiency was accepted, providing a pathway to regain compliance by October 29, 2026.
  • Strategic acquisitions are underway, including a 20% ownership interest in a defense-tech company (Tekne S.p.A.) and a SaaS startup, diversifying the business model.
  • The formation of Tekne US JV, an 80/20 joint venture with Tekne, is expected to generate up to $7.5 million in revenue from defense sector products for the Americas market while regulatory approvals are pending.

Negatives

  • NUBURU reported a significant increase in net loss to $28,836,400 for the six months ended June 30, 2025, compared to $18,343,981 in the prior year period.
  • Revenue for the six months ended June 30, 2025, was nil, indicating a complete halt in sales from its legacy laser business.
  • The company has a substantial accumulated deficit of $150,244,955 as of June 30, 2025, and critically low cash and cash equivalents of $111,090.
  • NUBURU received a Notice of Noncompliance from NYSE American due to insufficient stockholders' equity and recurring losses, posing a delisting risk.
  • The company's primary patent portfolio was foreclosed upon and transferred to secured lenders, significantly impacting its core laser technology assets.
  • Employee furloughs and resignations occurred in 2024 and continued into 2025 due to lack of funding, severely impacting operations and business plan execution.
  • The Series A Preferred Stock became mandatorily redeemable on January 31, 2025, but the company lacks legally available funds to effect the redemption, creating a significant financial obligation.
  • The company defaulted on its lease agreement, resulting in a default judgment of $409,278 and the write-down of all inventory, property, equipment, and right-of-use assets to zero.
  • NUBURU is facing legal claims, including a dispute with J.H. Darbie over advisory and finder's fees, which the company intends to vigorously defend.

Risks

  • Inability to predict the actual number of shares sold under the SEPA or the resulting gross proceeds, leading to uncertainty in funding.
  • Potential for substantial dilution for existing stockholders from future sales of common stock under the SEPA or other offerings.
  • Broad discretion over the use of SEPA proceeds, which may not yield significant returns or align with all investor expectations.
  • Sales of a substantial number of securities by existing securityholders could depress the market price of common stock.
  • Continued history of losses and the inability to achieve profitability in the future, raising substantial doubt about the company's ability to continue as a going concern.
  • Requirement for additional capital to finance operations and implement the Transformation Plan, with no assurance of obtaining it on acceptable terms, potentially forcing cessation of operations.
  • Risks associated with a rapid succession of strategic acquisitions, including adverse effects on day-to-day operations, cash flows, and financial condition due to integration difficulties, successor liabilities, and management diversion.
  • Difficulty managing growth in business, which could strain financial, operational, and management resources.
  • Lengthy sales and installation cycles for products, leading to significant expenses without offsetting revenues and increased risk of payment defaults or order cancellations.
  • Failure to meet customer price expectations, negatively impacting demand for products.
  • Dependence on government entities for a portion of revenue, subject to unpredictable budgetary cycles and policy changes.
  • High dependence on key executives and the ability to attract and retain qualified personnel, which could suffer due to competition or financial instability.
  • Uncertainty in achieving product launch targets due to reliance on internal assumptions, technical challenges, and supplier relationships.
  • Significant research and development expenses for new products, increasing losses and impacting profitability.
  • Inadequate insurance coverage for potential losses from product liability, accidents, or business disruptions.
  • Inability to execute on the new business model, leading to loss of investment.
  • Risks associated with international expansion, including cultural differences, compliance with foreign laws, intellectual property enforcement, currency fluctuations, and political conditions.
  • Hesitancy of potential customers to adopt novel technologies, impacting market acceptance.
  • Rapid technological changes in the market requiring significant R&D investment, with failure to adapt harming the business.
  • Litigation, regulatory actions, and compliance issues leading to fines, penalties, and negative publicity.
  • Increased costs and adverse effects on business opportunities due to privacy, information security, and data protection laws.
  • Negative impact from export controls, tariffs, and trade/economic sanctions laws.
  • Liability for environmental damages from operations, harming reputation and financial results.
  • Inability to protect, defend, maintain, or enforce intellectual property rights, leading to competitors offering similar products.
  • Exposure to third-party claims of intellectual property infringement or misappropriation, resulting in costly litigation or substantial liability.
  • Inability to protect intellectual property rights globally, especially in countries with weaker protections.
  • Claims of misappropriation of intellectual property from former employers or competitors.
  • Cyber-attacks and other disruptions, security breaches, and incidents harming business, reputation, and exposing to liability.
  • Natural disasters, unusual weather, epidemics, terrorist acts, and political events disrupting business operations.
  • Risk of delisting from NYSE American due to noncompliance with listing standards, limiting investor transactions and subjecting to additional trading restrictions.
  • Material weaknesses in internal control over financial reporting, potentially leading to inaccurate financial reporting and loss of investor confidence.
  • Limited experience of management in operating a public company.
  • Significant cash requirements and adverse tax consequences from the redemption of Preferred Stock.
  • Volatility in the stock price due to broad market fluctuations, low public float, and potential securities litigation.
  • Reliance on research and reports from industry or financial analysts, with negative coverage impacting stock price.
  • Anti-takeover provisions in governing documents delaying or preventing a change of control.
  • Potential for adverse amendments to Public Warrants without individual holder approval.
  • Significant dilution to stockholders from anti-dilution protection in outstanding convertible notes, preferred stock, and warrants.
  • Redemption of unexpired Public Warrants prior to exercise at a disadvantageous time, making them worthless.
  • Common Stock being subordinated to Preferred Stock in liquidation.

Future Outlook

NUBURU anticipates continued net losses for the foreseeable future as it implements its Transformation Plan, which involves diversifying its asset base through strategic acquisitions in defense-tech, security, and operational resilience. The company plans to focus its laser business on licensing and joint development within specific verticals and outsource manufacturing. Future operations will rely on capital raising efforts, including sales under the SEPA, and the successful consummation and integration of announced acquisitions, which are subject to regulatory and stockholder approvals. The company expects to incur significant R&D expenses and increase headcount to support its growth and public company operations.

Management Comments

  • Management initiated measures designed to reduce costs, which included implementing a furlough of employees during the last two quarters of 2024, significantly impacting operations and the ability to pursue the business plan.
  • If unable to obtain additional financing or implement the Transformation Plan, the company will not be able to sustain operations and will need to consider alternatives, including a sale, liquidation, or dissolution of the business.
  • The company believes that, upon consummation of certain recently announced transactions, it will be able to regain compliance with NYSE American listing standards, though these transactions are subject to approvals and may not achieve anticipated results.
  • The company is adapting its research and development to focus on strategic licensing and applications in the defense industry following the foreclosure of its patent portfolio.
  • The company is pursuing a lease for a replacement facility more appropriate for its new business strategy, which will involve laser development in different verticals and outsourcing of manufacturing and inventory management.

Industry Context

NUBURU operates in the rapidly evolving laser system industry, characterized by significant price and technological competition from mature players like Coherent, nLight, IPG Photonics, and Trumpf, as well as development-stage competitors. The company's blue laser technology offers advantages in efficiency, speed, and quality for applications like welding and 3D printing, but faces competition from conventional infrared and green lasers. The company is strategically diversifying into defense-tech, security, and operational resilience, indicating a pivot away from its original core market due to competitive pressures and financial constraints. This diversification aligns with broader trends of technology companies seeking new growth avenues and leveraging existing capabilities in adjacent markets, particularly those with government contracts.

Comparison to Industry Standards

  • NUBURU's blue industrial laser technology offers key advantages such as high energy process efficiency, higher speed without pre-heating, greater part strength, lower electrical resistance, superior part quality, and smaller part size compared to conventional infrared (IR) lasers.
  • Compared to Infrared Fiber and Disc Lasers, NUBURU's blue lasers avoid issues like spatter and pores in welds, reduce weld time by up to 10x by eliminating the need for scan heads, and lower capital costs associated with scan heads and driving software.
  • Against Infrared Fiber Ring Lasers, NUBURU's blue lasers show a typically 20% improvement in absorption and avoid the complexity, inefficiency, and consumable nature of frequency doubling crystals found in green lasers.
  • Green lasers, while an improvement over IR, have significant drawbacks including lower absorption compared to blue lasers (20% less efficient) and higher complexity and poor electrical conversion efficiency due to the need for frequency doubling and consumable crystals.
  • Other blue lasers, typically based on bar arrays, produce lower brightness and larger spot sizes or shorter standoff distances compared to NUBURU's single chip approach used in its BLTM line of products.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Executive ChairmanRon Nicol (former)Alessandro Zamboni2025-01-13Appointed in connection with the Transformation Plan and SFE EI letter agreement.
DirectorJohn BoltonNA2024-04-30Resignation.
DirectorKristi HummelNA2024-10-21Resignation.
DirectorLily Yan HughesNA2024-10-21Resignation.
Chief Executive Officer and DirectorBrian KnaleyNA2025-01-31Resignation, continued support via special projects until July 2025.
DirectorElizabeth MoraNA2025-01-31Resignation.
DirectorDaniel HirschNA2025-01-31Resignation.
DirectorNAShawn Taylor2025-01-01Appointment to the Board.
DirectorNADario Barisoni2025-01-01Appointment to the Board.
DirectorNAMatteo Ricchebuono2025-01-01Appointment to the Board.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Stockholder ApprovalStockholders approved issuances of Common Stock in excess of 19.9% of outstanding Common Stock for the SEPA and Indigo Capital Convertible Notes at the 2025 Annual Meeting.2025-07-09Enables the company to utilize these financing mechanisms without being constrained by NYSE American's 19.99% rule, crucial for capital raising and debt conversion.
Authorized Share Capital IncreaseThe number of authorized shares of Common Stock was increased from 250,000,000 to 900,000,000, and Preferred Stock remained at 50,000,000.2025-07-22Provides greater flexibility for future equity issuances, including for capital raises, acquisitions, and debt conversions, but also increases potential for dilution.
Board CompositionThe Board consists of a majority of independent directors, as defined under NYSE American rules.2025-01-01Maintains compliance with exchange listing requirements for board independence, enhancing corporate governance oversight.
Related Party Transaction Policy AdherenceRelated party transactions, such as loans from the Executive Chairman and investments in entities where he holds a controlling interest, are negotiated and approved by independent board members.NAMitigates potential conflicts of interest and ensures transactions are conducted in the company's best interest, as per the related person transactions policy.

Legal Proceedings

  • CFGI, LLC obtained a default judgment of $86,826 against the company in March 2025.
  • FICTIV, Inc. obtained a default judgment of $197,899 against the company on January 30, 2025, which was subsequently settled.
  • The company's landlord (Centennial Tech Industrial Owner, LLC) obtained a default judgment of $409,278 in April 2025 due to lease default, accruing 10% annual interest.
  • J.H. Darbie initiated a legal claim against the company for advisory services ($500,000 payable in stock) and a Finders Fee, which the company intends to vigorously defend, asserting advisory services were not provided.

Related Party Transactions

  • Standby Equity Purchase Agreement (SEPA) with YA II PN, LTD. (Selling Stockholder) for up to $100 million in common stock sales.
  • Letter agreement with S.F.E. Equity Investments SARL (SFE EI) on January 13, 2025, for financing operations and committing capital for the Transformation Plan.
  • Settlement and mutual release agreement with Liqueous LP (January/April 2025) resolving disputes, involving payments to the company, modification/exercise of pre-funded warrants, and issuance of common stock for the Liqueous Obligation.
  • Multiple convertible notes issued to Indigo Capital LP (March, April, July, August 2025) for capital infusions and extinguishment of other notes/obligations.
  • Business Loan and Security Agreement with Agile Capital Funding, LLC (May 2025) for a secured promissory note, later refinanced.
  • Securities Purchase Agreements with 1800 Diagonal Lending LLC (May, July 2025) for convertible promissory notes.
  • Securities Purchase Agreement with Boot Capital LLC (May 2025) for a convertible promissory note.
  • Convertible note transactions with Brick Lane Capital Management Limited (June 2025) for capital and transfer of Series A Preferred Stock.
  • Convertible note transactions with Bomore Opportunity Group Ltd (June 2025) for capital and transfer of Series A Preferred Stock.
  • Convertible note transactions with Torcross Capital LLC (June 2025) for capital and transfer of Series A Preferred Stock.
  • Yorkville Promissory Note (June 30, 2025, closed July 2025) for $1.1 million capital infusion, with SEPA proceeds required for repayment.
  • TAG Promissory Note issued to The AvantGarde Group (owned by Executive Chairman Alessandro Zamboni) in January 2025 for $545,000.
  • Working Capital Loan of $900,000 from Executive Chairman Alessandro Zamboni in May 2025, from his proceeds of the TCEI acquisition, loaned back to the company.
  • Acquisition plan for a controlling interest in a SaaS startup (1AF2 S.r.l.) where Executive Chairman Alessandro Zamboni owns a controlling interest.
  • Strategic investment in Supply@ME Capital Plc (SYME) via a convertible facility, where Executive Chairman Alessandro Zamboni is the founder and current Chief Executive Officer.
  • Settlement with Silverback Capital Corporation (July 17, 2025) for $5,662,479 in claims, payable in Common Stock.

Stakeholder Impact

  • Shareholders face significant dilution risk from the ongoing and planned issuance of common stock through the SEPA, convertible notes, and acquisitions.
  • Existing shareholders may experience a decline in share price due to the substantial number of shares offered for resale and the company's distressed financial condition.
  • Employees have been impacted by furloughs and resignations due to lack of funding, potentially affecting morale and operational stability.
  • Creditors are subject to the company's liquidity constraints, as evidenced by default judgments and the inability to redeem Preferred Stock, though some claims have been settled through stock issuances.
  • Customers may face uncertainty regarding product availability and support due to the company's operational disruptions, asset impairments, and strategic pivot away from full-scale manufacturing.
  • Suppliers may experience payment delays or non-payment, as indicated by outstanding payables and legal proceedings for default judgments.

Next Steps

  • Continue to sell shares of Common Stock to the Selling Stockholder under the SEPA to raise working capital and fund the Transformation Plan.
  • Pursue regulatory approvals (e.g., Italian government's Golden Power review) and stockholder approval for the second stage of the Tekne acquisition.
  • Complete the acquisition of a 3% equity interest in Tekne in September 2025.
  • Provide EUR 10.5 million cash financing to Tekne and facilitate a EUR 30 million inventory monetization program via the SYME platform.
  • Form the U.S.-based joint venture (Tekne US JV) to develop, manufacture, and sell defense products in the Americas market.
  • Negotiate and execute definitive agreements for the modified Tekne acquisition terms.
  • Work towards regaining compliance with NYSE American's continued listing standards by October 29, 2026.
  • Recruit and retain additional management, human resources, accounting, finance, technical, engineering, and sales personnel to support strategic objectives.
  • Pursue a lease for a replacement facility appropriate for the new business strategy, involving laser development in different verticals and outsourced manufacturing.

Key Dates

DateDescription
2020-07-21NUBURU, Inc. (f/k/a Tailwind Acquisition Corp.) originally incorporated in Delaware.
2020-09-09Consummation of the company's initial public offering (IPO).
2022-08-30Legacy Nuburu entered into a Services Agreement with Anzu Partners.
2023-01-31Consummation of the business combination with Legacy Nuburu, changing the company's name to NUBURU, Inc. and becoming the owner of Legacy Nuburu. Also, the two-year anniversary of the issuance of Preferred Stock, making it mandatorily redeemable.
2023-06-12Company entered into Note and Warrant Purchase Agreements for Senior Convertible Notes.
2023-06-16Company entered into Note and Warrant Purchase Agreements for Senior Convertible Notes and a Registration Rights and Lock-Up Agreement.
2023-11-13Company entered into Junior Note Purchase Agreements for Junior Notes and Junior Note Warrants.
2023-12-12NYSE American notified the company of delisting proceedings for its Public Warrants due to low trading price levels.
2024-02-22Stockholders approved proposals to authorize a reverse stock split.
2024-05-01Company entered into a Pre-Funded Warrant Purchase Program with strategic investors.
2024-06-13NYSE American announced delisting proceedings for the company's Common Stock, and trading was immediately suspended.
2024-07-23Company effected a 1-for-40 reverse stock split.
2024-07-29NYSE American notified the company that it had resolved the low selling price deficiency and lifted the trading suspension.
2024-08-02Common Stock re-commenced trading on NYSE American.
2024-08-06Company entered into a subordinated convertible note agreement with Esousa Group Holdings LLC for August 2024 Convertible Notes.
2024-08-19Company entered into another subordinated convertible note agreement with Esousa Group Holdings LLC for August 2024 Convertible Notes.
2024-10-01Company entered into a Master Transaction Summary agreement and an unsecured promissory note with Liqueous LP.
2024-12-16Lead Investor issued a notice of default and acceleration for Senior Convertible Notes.
2025-01-13Company entered into a letter agreement with S.F.E. Equity Investments SARL (SFE EI) for financing and the Transformation Plan.
2025-01-14Company entered into a settlement and mutual release agreement with Liqueous LP.
2025-01-30FICTIV, Inc. obtained a default judgment against the company.
2025-01-31Brian Knaley resigned as Chief Executive Officer and a director of the Company. Preferred Stock reclassified from mezzanine equity to a current liability.
2025-02-17Company entered into an amendment to the Liqueous Settlement Agreement, modifying pre-funded warrants.
2025-02-19Company entered into a commitment letter with Trumar Capital LLC for acquisitions.
2025-02-28Company entered into a share exchange agreement and master distribution agreement with HUMBL, Inc. (subsequently terminated).
2025-03-01Company and Phoenix MGMT Consulting LLC entered into a consulting agreement.
2025-03-03Company entered into convertible note transactions with Indigo Capital LP.
2025-03-05Secured lenders concluded the foreclosure sale of the company's patent portfolio, extinguishing Junior and Senior Convertible Notes.
2025-03-14Company entered into a convertible facility with Supply@ME Capital Plc (SYME).
2025-03-31Company entered into a Joint Pursuit Agreement with Tekne.
2025-04-22Company entered into additional convertible note transactions with Indigo Capital LP.
2025-04-29Company received a Notice of Noncompliance from NYSE Regulation.
2025-05-12Company entered into a Business Loan and Security Agreement with Agile Capital Funding, LLC.
2025-05-13Company entered into Securities Purchase Agreements with 1800 Diagonal Lending LLC and Boot Capital LLC.
2025-05-30Company entered into a Standby Equity Purchase Agreement (SEPA) with YA II PN, LTD. and refinanced its existing loan with Agile Capital Funding, LLC.
2025-06-03Company entered into convertible note transactions with Brick Lane Capital Management Limited.
2025-06-05Issuance of 1,332,623 shares of Common Stock to the SEPA Investor as part of the commitment fee.
2025-06-18Company entered into convertible note transactions with Bomore Opportunity Group Ltd.
2025-06-25Company entered into convertible note transactions with Torcross Capital LLC.
2025-06-30Company entered into a securities purchase agreement for the Yorkville Promissory Note (closed July 2025).
2025-07-09Company's stockholders approved various proposals at the Annual Meeting, including increasing authorized shares and exceeding the 19.99% Share Cap for certain issuances.
2025-07-15Issuance of remaining 1,332,623 shares of Common Stock to the SEPA Investor as part of the commitment fee.
2025-07-16Company issued a convertible note to Indigo Capital LP (July Indigo Capital Convertible Note).
2025-07-17Company and Silverback Capital Corporation agreed to settle outstanding claims.
2025-07-21Company entered into a Securities Purchase Agreement with 1800 Diagonal Lending LLC (July Diagonal Convertible Note).
2025-07-22NYSE American accepted the company's Compliance Plan. Company filed Certificate of Amendment to increase authorized shares.
2025-07-24A registration statement for the resale of up to 20 million shares of Common Stock under the SEPA was declared effective by the SEC.
2025-07-30State court approved the settlement with Silverback Capital Corporation.
2025-08-18Company issued a convertible note to Indigo Capital LP (August Indigo Capital Convertible Note).
2025-08-20Last quoted sale price for Common Stock was $0.1630 per share. Number of outstanding shares of Common Stock was 99,829,078.
2025-08-27Company executed a binding commitment letter with shareholders of Tekne, modifying acquisition terms.
2025-08-29Date of this S-1 filing.
2025-09-01Expected date for the first tranche of EUR 10.5 million cash financing for Tekne's working capital needs.
2025-09-01Expected date for the acquisition of a 3% equity interest in Tekne (First Stage).
2025-10-30Maturity date for the Yorkville Promissory Note.
2025-12-31Expected date for the acquisition of the remaining 67% interest in Tekne (Second Stage).
2026-02-28Maturity date for the Diagonal Convertible Note and Boot Convertible Note.
2026-03-01Maturity date for the March Indigo Capital Convertible Notes.
2026-04-21Maturity date for the April Indigo Capital Convertible Notes.
2026-06-02Maturity date for a Brick Lane convertible note.
2026-06-17Maturity date for the Bomore Convertible Notes.
2026-06-24Maturity date for the Torcross Convertible Notes.
2026-07-15Maturity date for the July Indigo Capital Convertible Note.
2026-08-17Maturity date for the August Indigo Capital Convertible Note.
2026-10-29Deadline to regain compliance with NYSE American continued listing standards.
2028-05-30Automatic termination date for the SEPA (36-month anniversary).
2028-06-23Expiration date for the Senior Note Warrants.
2028-12-06Expiration date for the Junior Note Warrants.
2029-08-01Expiration date for August 2024 Warrants Issued with Junior Notes.
2030-02-01Expiration date for February 2025 Pre-Funded Warrants.
2035-01-01Start of expiration period for certain federal and state NOL carryforwards.
2044-12-31End of expiration period for federal research credit carryforwards.

Recommendation

strong sell

NUBURU is in a highly distressed financial state, evidenced by increasing net losses, nil revenue, critically low cash reserves, and an explicit 'going concern' warning from its auditors. The company has lost its core patent portfolio through foreclosure, impaired all its physical assets, and faces delisting from NYSE American. While management is attempting a strategic pivot through acquisitions and various capital raises, these efforts are highly speculative, involve significant related-party transactions, and are subject to numerous regulatory and stockholder approvals. The substantial dilution from ongoing and planned equity issuances, coupled with the company's inability to meet its preferred stock redemption obligations, presents an extremely high risk profile. The current share price of $0.1630 reflects this distress, and further downside is highly probable given the severe operational and financial challenges. A seasoned investor would recognize the immense uncertainty and lack of a clear path to sustainable profitability, making a 'strong sell' recommendation appropriate.

Keywords

NUBURU, BURU, S-1, SEC Filing, Standby Equity Purchase Agreement, SEPA, Common Stock Resale, Dilution, Going Concern, Net Loss, NYSE American Noncompliance, Delisting Risk, Strategic Acquisitions, Defense Technology, SaaS, Operational Resilience, Tekne S.p.A., Supply@ME Capital Plc, Inventory Monetisation, Convertible Notes, Preferred Stock Redemption, Patent Foreclosure, Intellectual Property, Financial Distress, Capital Raise, Reverse Stock Split

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.